ST Pharm company officials gathered last week for the groundbreaking of its second manufacturing plant in Ansan.

Photo courtesy of ST Pharm

Pharmaceutical manufacturer ST Pharm recently held its groundbreaking ceremony for its second oligonucleotide plant in the South Korean city of Ansan, located in Gyeonggi Province. The $830.9 million investment goes toward the build-out of a seven-story, 117,326-sq.-ft. facility. Large, medium and small-scale production will take place on the first five levels of the building, while the sixth and seventh levels serve as reserve spaces that would allow for two additional large-scale production lines to support future growth. ST Pharm plans to integrate an advanced automation system to control operations and eco-friendly features for heating, water and cleaning technologies. The company anticipates reaching $746 million in oligonucleotide sales by 2030 as the facility’s production capacity will average two to seven tons of oligonucleotide active pharmaceutical ingredient annually. According to the company, this move signifies the first step to becoming a global leader in the oligonucleotide contract development and manufacturing organization domain.

ADVERTISEMENT

Fidelis plans to bring its Mountaineer GigaSystem ™ and Monarch Cloud Campus ™ to West Virginia by 2028.

Rendering courtesy of Fidelis New Energy

Energy transition company Fidelis New Energy has plans for an $8 billion net-zero carbon hydrogen production facility in Mason, West Virginia, located at a bend in the Ohio River between Huntington and Parkersburg. The site will feature a low carbon microgrid for the company’s planned data centers, featuring FidelisH2® technology that allows for hydrogen production with net-zero carbon emissions. The company selected carbon storage site developer Battelle Carbon Solutions to handle subsurface data collection for safe carbon sequestration produced by the project. Construction will take place over four phases costing about $2 billion each, with the first phase expected to be operational by 2028. Hydrogen produced at the site will be used for the data center campus, planned greenhouse system, transportation and steel production. The site will produce 500 metric tons of hydrogen per day, equating to 10 million metric tons of CO2 to be permanently stored per year.

ADVERTISEMENT

Ams Osram plans to invest over $1 billion in expansions at its sites in Germany and Malaysia.

Photo courtesy of Ams Osram

Austria-based semiconductor manufacturer Ams Osram announced plans to upgrade its 50-year-old Regensburg, Germany, site with the support of $318 million from Germany’s Federal Ministry for Economic Affairs and Climate Action. The company did not disclose how much it would be investing in the expansion, although it has said that around $1.07 billion would be going toward its Kulim, Malaysia, and Regensburg operations. With governmental support Ams Osram will introduce 8-inch micro-LED fabrication to replace the current 6-inch wafer processes, allowing for economical production in comparison. LEDs produced at this site primarily cater toward automotive, industrial and horticultural uses. Funding will be used to introduce production of micro-LEDs used for “an all-new type of display,” which the company did not provide further details about, and UV-C LEDs. In addition, the company plans to invest in new clean room and lab facilities for R&D and pilot production. Construction has begun on the site and the expansion will create 400 new jobs upon completion.

Reports compiled and written by Alexis Elmore